Contact

In the project ‚TICARDIO‘, doctoral students study the interaction of inflammation and thromboses. Their approach contributes to improving the treatment of cardiovascular disease.
Bernhard Blank-Landeshammer developed a method that makes it possible to identify peptides in tissue samples using mass spectrometry. It combines information on genomics, proteomics and transcriptomics.
Since the beginning of August, a pharmacy student from Italy has been a guest at ISAS for the first time. Anna Percio from the Catholic University of the Sacred Heart in Rome talks about her experiences in the ERC group Sulfaging.
Coronary artery disease is the leading cause of death worldwide, according to the World Health Organisation. Therefore, scientists at ISAS are studying the phase after an acute infarction to find new therapeutic approaches.
Thibaut Vignane’s goal is to shed light on the molecular mechanisms by which persulfidation controls the ageing of human cells. In the interview, he explains what this has to do with space travel.
Using chemical probes, Prof Dr Steven Verhelst and his Team study intramembrane proteases. These are associated with Alzheimer's and diabetes type II. As part of their research, the scientists develop molecular tools at ISAS.